Po–Sung Chu - Concepedia

Author

Po–Sung Chu

Also Known As

Chu Po-Sung, P.-S Chu, P.-S. Chu, P.S. Chu, Po Sung Chu, Po-Sung Chu, Po-sung Chu, Po‐Sung Chu, Po‐sung Chu, Po–Sung Chu

Publications

Citations

H-Index

Concepts

All Affiliations

Keio University Mitsubishi Tanabe Pharma Corporation Japan Agency for Medical Research and Development Mita Hospital Keio University Hospital

About

Po–Sung Chu is an author at Keio University specializing in medicine, immunology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.3K
2	Health Sciences	4	4	253
3	Allergy	2	2	92
4	Language Studies	1	1	11
5	Biochemistry	1	1	40

Po–Sung Chu

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis Nobuhiro Nakamoto, Nobuo Sasaki, Ryo Aoki, Nature Microbiology InflammationDysbiosisAutoimmune DiseaseMucosal ImmunologyImmunology	2019	400
The liver–brain–gut neural arc maintains the Treg cell niche in the gut Toshiaki Teratani, Yohei Mikami, Nobuhiro Nakamoto, Nature Treg Cell NicheDevelopmental BiologyBiliary TractLiver–brain–gut Neural ArcLiver Physiology	2020	243
CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells Yuzo Koda, Toshiaki Teratani, Po–Sung Chu, Nature Communications	2021	188
Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan® Hirotoshi Ebinuma, Hidetsugu Saito, Mina Komuta, Journal of Gastroenterology Biomedical AcousticsLiver FibrosisHepatologyMedical ImagingAbdominal Imaging	2011	108
C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice Po–Sung Chu, Nobuhiro Nakamoto, Hirotoshi Ebinuma, Hepatology	2013	94
Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis Masataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo‐Russo, Nature Communications DysbiosisLytic Phage CocktailKlebsiella PneumoniaeImmunologyBacteriophage	2023	94
CCR9+ Macrophages Are Required for Acute Liver Inflammation in Mouse Models of Hepatitis Nobuhiro Nakamoto, Hirotoshi Ebinuma, Takanori Kanai∥, Gastroenterology InflammationLiver FibrosisHepatologyLiver PhysiologyImmunology	2011	82
Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice Nobuhiro Nakamoto, T Amiya, Ryo Aoki, Cell Reports DysbiosisMicrobial PathogensInnate Immune SystemImmunologyImmune Regulation	2017	80
On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C Po–Sung Chu, Nobuhiro Nakamoto, Nobuhito Taniki, PLoS ONE	2017	63
Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus Kazuo Sugiyama, Hirotoshi Ebinuma, Nobuhiro Nakamoto, PLoS ONE Prominent SteatosisHepatitis C VirusCell Line PermissiveImmunologyPathology	2014	40

Page 1